Daiwa Securities Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $24.1M | Buy |
38,643
+2,118
| +6% | +$1.44M | 0.05% | 217 |
|
|
2026
Q1 | $28.2M | Buy |
36,525
+6,754
| +23% | +$5.17M | 0.08% | 138 |
|
|
2025
Q4 | $23M | Sell |
29,771
-2,058
| -6% | -$1.4M | 0.07% | 165 |
|
|
2025
Q3 | $17.9M | Buy |
31,829
+7,500
| +31% | +$4.24M | 0.06% | 187 |
|
|
2025
Q2 | $12.8M | Buy |
24,329
+761
| +3% | +$425K | 0.05% | 235 |
|
|
2025
Q1 | $14.9M | Buy |
23,568
+1,906
| +9% | +$1.31M | 0.06% | 189 |
|
|
2024
Q4 | $15.4M | Buy |
21,662
+1,278
| +6% | +$1.07M | 0.07% | 169 |
|
|
2024
Q3 | $21.4M | Buy |
20,384
+2,234
| +12% | +$2.49M | 0.1% | 127 |
|
|
2024
Q2 | $19.1M | Buy |
18,150
+949
| +6% | +$920K | 0.1% | 123 |
|
|
2024
Q1 | $16.6M | Buy |
17,201
+2,115
| +14% | +$2.01M | 0.09% | 127 |
|
|
2023
Q4 | $13.3M | Buy |
15,086
+878
| +6% | +$723K | 0.08% | 140 |
|
|
2023
Q3 | $11.9M | Buy |
14,208
+1,528
| +12% | +$1.2M | 0.08% | 140 |
|
|
2023
Q2 | $9.11M | Buy |
12,680
+21
| +0.2% | +$16.2K | 0.06% | 175 |
|
|
2023
Q1 | $10.4M | Buy |
12,659
+634
| +5% | +$478K | 0.07% | 157 |
|
|
2022
Q4 | $8.68M | Buy |
12,025
+359
| +3% | +$265K | 0.07% | 179 |
|
|
2022
Q3 | $8.04M | Buy |
11,666
+667
| +6% | +$420K | 0.07% | 173 |
|
|
2022
Q2 | $6.72M | Buy |
10,999
+631
| +6% | +$410K | 0.05% | 205 |
|
|
2022
Q1 | $7.58M | Buy |
10,368
+939
| +10% | +$594K | 0.05% | 208 |
|
|
2021
Q4 | $6.42M | Buy |
9,429
+226
| +2% | +$139K | 0.04% | 246 |
|
|
2021
Q3 | $6.2M | Buy |
9,203
+1,323
| +17% | +$821K | 0.04% | 220 |
|
|
2021
Q2 | $4.4M | Buy |
7,880
+238
| +3% | +$121K | 0.03% | 267 |
|
|
2021
Q1 | $3.62M | Buy |
7,642
+826
| +12% | +$402K | 0.03% | 284 |
|
|
2020
Q4 | $3.29M | Buy |
6,816
+359
| +6% | +$194K | 0.03% | 279 |
|
|
2020
Q3 | $3.61M | Sell |
6,457
-999
| -13% | -$606K | 0.03% | 221 |
|
|
2020
Q2 | $2.16M | Hold |
7,456
| – | – | 0.05% | 217 |
|
|
2020
Q1 | $3.64M | Sell |
7,456
-1,507
| -17% | -$622K | 0.04% | 207 |
|
|
2019
Q4 | $3.37M | Sell |
8,963
-135
| -1% | -$45.4K | 0.03% | 254 |
|
|
2019
Q3 | $2.52M | Buy |
9,098
+1,881
| +26% | +$557K | 0.02% | 300 |
|
|
2019
Q2 | $2.26M | Buy |
7,217
+222
| +3% | +$73.9K | 0.02% | 306 |
|
|
2019
Q1 | $2.87M | Sell |
6,995
-2,373
| -25% | -$977K | 0.03% | 264 |
|
|
2018
Q4 | $4.32M | Sell |
9,368
-2,490
| -21% | -$911K | 0.04% | 203 |
|
|
2018
Q3 | $4.79M | Sell |
11,858
-2,070
| -15% | -$788K | 0.04% | 226 |
|
|
2018
Q2 | $5.05M | Buy |
13,928
+1,075
| +8% | +$336K | 0.04% | 230 |
|
|
2018
Q1 | $4.63M | Buy |
12,853
+9,433
| +276% | +$3.28M | 0.04% | 239 |
|
|
2017
Q4 | $1.29M | Sell |
3,420
-11,942
| -78% | -$4.84M | 0.01% | 452 |
|
|
2017
Q3 | $6.87M | Sell |
15,362
-1,295
| -8% | -$616K | 0.05% | 177 |
|
|
2017
Q2 | $8.18M | Sell |
16,657
-1,002
| -6% | -$438K | 0.05% | 142 |
|
|
2017
Q1 | $6.84M | Buy |
17,659
+11,486
| +186% | +$4.26M | 0.04% | 171 |
|
|
2016
Q4 | $2.27M | Sell |
6,173
-3,910
| -39% | -$1.49M | 0.01% | 261 |
|
|
2016
Q3 | $4.05M | Buy |
10,083
+2,183
| +28% | +$876K | 0.02% | 190 |
|
|
2016
Q2 | $2.76M | Sell |
7,900
-7,975
| -50% | -$3.07M | 0.02% | 246 |
|
|
2016
Q1 | $5.72M | Buy |
15,875
+2,320
| +17% | +$956K | 0.04% | 157 |
|
|
2015
Q4 | $7.36M | Sell |
13,555
-5,675
| -30% | -$3.07M | 0.05% | 127 |
|
|
2015
Q3 | $8.94M | Sell |
19,230
-640
| -3% | -$344K | 0.06% | 116 |
|
|
2015
Q2 | $10.1M | Buy |
19,870
+2,440
| +14% | +$1.19M | 0.07% | 122 |
|
|
2015
Q1 | $7.87M | Buy |
17,430
+3,630
| +26% | +$1.54M | 0.05% | 126 |
|
|
2014
Q4 | $5.66M | Buy |
13,800
+10,630
| +335% | +$4.18M | 0.04% | 139 |
|
|
2014
Q3 | $1.14M | Buy |
3,170
+1,070
| +51% | +$359K | 0.01% | 278 |
|
|
2014
Q2 | $593K | Sell |
2,100
-100
| -5% | -$29.6K | ﹤0.01% | 369 |
|
|
2014
Q1 | $661K | Hold |
2,200
| – | – | 0.01% | 346 |
|
|
2013
Q4 | $606K | Hold |
2,200
| – | – | 0.01% | 352 |
|
|
2013
Q3 | $688K | Hold |
2,200
| – | – | 0.01% | 328 |
|
|
2013
Q2 | $495K | Buy |
+2,200
| New | +$512K | ﹤0.01% | 417 |
|
Other funds holding REGN
Daiwa Securities Group's REGN Position: Q2 2026 in Review
Daiwa Securities Group increased its Regeneron Pharmaceuticals (REGN) stake by 5.8% in Q2 2026, buying an estimated $1.44M and bringing the position to 38,643 shares worth $24.1M. The position accounts for 0.05% of the portfolio, ranked #217.
Daiwa Securities Group first reported a position in REGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $28.2M in Q1 2026. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Daiwa Securities Group held 38,643 shares of Regeneron Pharmaceuticals worth $24.1M as of Q2 2026.
- Daiwa Securities Group bought 2,118 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $1.44M.
- Regeneron Pharmaceuticals made up 0.05% of Daiwa Securities Group's portfolio in Q2 2026, its #217 holding.
- Daiwa Securities Group first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Daiwa Securities Group's Regeneron Pharmaceuticals position peaked at $28.2M in Q1 2026.
- 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Daiwa Securities Group's 13F filing for Q2 2026, filed 31 Jul 2026.